Consun Pharmaceutical Group Ltd. (HK:1681) has released an update.
Consun Pharmaceutical Group Ltd. is making a second attempt to amend its memorandum and articles of association to comply with Hong Kong’s new paperless listing regime. The proposed changes, which require shareholder approval, aim to streamline corporate communications through electronic means. These adjustments reflect the company’s efforts to align with evolving regulatory standards.
For further insights into HK:1681 stock, check out TipRanks’ Stock Analysis page.
